0001209191-22-021022.txt : 20220324 0001209191-22-021022.hdr.sgml : 20220324 20220324211009 ACCESSION NUMBER: 0001209191-22-021022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220322 FILED AS OF DATE: 20220324 DATE AS OF CHANGE: 20220324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Imran Talat CENTRAL INDEX KEY: 0001869579 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40672 FILM NUMBER: 22768053 MAIL ADDRESS: STREET 1: C/O RANI THERAPEUTICS HOLDINGS, INC. STREET 2: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001856725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: (408) 457-3700 MAIL ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-22 0 0001856725 Rani Therapeutics Holdings, Inc. RANI 0001869579 Imran Talat C/O RANI THERAPEUTICS LLC 2051 RINGWOOD AVE. SAN JOSE CA 95131 1 1 0 0 Chief Executive Officer Class A Common Stock 2022-03-22 4 A 0 86600 0.00 A 98943 D Stock Option (Right to Buy) 13.21 2022-03-22 4 A 0 263400 0.00 A 2032-03-21 Class A Common Stock 263400 263400 D The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022. /s/ Josh Seidenfeld, Attorney-in-Fact for Talat Imran 2022-03-24